Grove AI
Grove AI helps clinical research teams recruit, engage, and retain study participants using AI-driven Participant Relationship Management and automated digital staff. The platform combines machine learning models with PRM workflows and conversational automation to streamline outreach, scheduling, and follow-up across trials. Grove AI is delivered as a B2B SaaS solution for sponsors, contract research organizations, and clinical sites. Key technologies include AI/ML-powered automation and digital staff agents tailored for clinical trial operations. The company targets the clinical trials market to reduce operational friction and improve participant experience and retention rates.
Grove AI
Grove AI helps clinical research teams recruit, engage, and retain study participants using AI-driven Participant Relationship Management and automated digital staff. The platform combines machine learning models with PRM workflows and conversational automation to streamline outreach, scheduling, and follow-up across trials. Grove AI is delivered as a B2B SaaS solution for sponsors, contract research organizations, and clinical sites. Key technologies include AI/ML-powered automation and digital staff agents tailored for clinical trial operations. The company targets the clinical trials market to reduce operational friction and improve participant experience and retention rates.
TL;DR
What they do: AI-powered Participant Relationship Management (PRM) and digital staff agents for clinical trial recruitment, scheduling, and engagement
Founded: 2024
Headquarters: San Francisco, CA
Recent funding: $4.9M seed (Jan 2025) led by A*
Product highlight: Grace — voice/SMS AI agent with IRB generic approval for recruitment/engagement
Company Overview
Problem Domain
Clinical trial recruitment, participant engagement, and retention
Founded
2024
Industry
Biotechnology
Tech Stack
Funding Track Record
$4.9M
Participation from Afore Capital, LifeX Ventures, Pear VC, Upfront Ventures, and angel investors including Ajit Baid, Chloe Yoo, Phuc Truong, and Till Pieper
Investor Signal
“Participation from multiple prominent seed investors (A*, Afore Capital, LifeX Ventures, Pear VC, Upfront Ventures) and industry angels”